Lipid Management in Human Immunodeficiency Virus

被引:0
作者
Myerson, Merle [1 ,2 ]
机构
[1] Mt Sinai Roosevelt, Mt Sinai St Lukes, Inst Adv Med HIV, Cardiovasc Dis Prevent Program, New York, NY 10025 USA
[2] Mt Sinai Roosevelt, Mt Sinai St Lukes, Inst Adv Med HIV, Lipid Clin,Cardiol Sect, New York, NY 10025 USA
关键词
HIV; Dyslipidemia; Cardiovascular risk factors; Antiretroviral therapy; Infectious diseases; HIV-INFECTED PATIENTS; ACTIVE ANTIRETROVIRAL THERAPY; LOW-DENSITY-LIPOPROTEIN; CARDIOLOGY/AMERICAN HEART ASSOCIATION; POLYUNSATURATED FATTY-ACIDS; EXTENDED-RELEASE NIACIN; 2013; AMERICAN-COLLEGE; CARDIOVASCULAR-DISEASE; LDL-CHOLESTEROL; FISH-OIL;
D O I
10.1016/j.ccl.2015.01.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The development of antiretroviral medications to treat patients infected with HIV has changed this disease from one that was fatal to a chronic and more manageable condition. However, these patients are at increased risk for cardiovascular disease due to the HIV itself, use of antiretroviral medications, and because they are living to an age when cardiovascular disease is more prevalent. At present there are no specific guidelines for management of risk factors, in particular dyslipidemia, for this patient population. We present recommendations based on those for the general population and how these may be applied to patients living with HIV.
引用
收藏
页码:277 / +
页数:23
相关论文
共 116 条
[31]   Drug-Drug Interactions Between HMG-CoA Reductase Inhibitors (Statins) and Antiviral Protease Inhibitors [J].
Chauvin, Benoit ;
Drouot, Sylvain ;
Barrail-Tran, Aurelie ;
Taburet, Anne-Marie .
CLINICAL PHARMACOKINETICS, 2013, 52 (10) :815-831
[32]   Short-term ezetimibe is well tolerated and effective in combination with statin therapy to treat elevated LDL cholesterol in HIV-infected patients [J].
Chow, Dominic ;
Chen, Huichao ;
Glesby, Marshall J. ;
Busti, Anthony ;
Souza, Scott ;
Andersen, Janet ;
Kohrs, Sharon ;
Wu, Julia ;
Koletar, Susan L. .
AIDS, 2009, 23 (16) :2133-2141
[33]   Ezetimibe effectively decreases LDL-cholesterol in HIV-infected patients [J].
Coll, Blai ;
Aragones, Gerard ;
Parra, Sandra ;
Alonso-Villaverde, Carlos ;
Masana, Lluis .
AIDS, 2006, 20 (12) :1675-1677
[34]   LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study-Implications for LDL management [J].
Cromwell, William C. ;
Otvos, James D. ;
Keyes, Michelle J. ;
Pencina, Michael J. ;
Sullivan, Lisa ;
Vasan, Ramachandran S. ;
Wilson, Peter W. F. ;
D'Agostino, Ralph B. .
JOURNAL OF CLINICAL LIPIDOLOGY, 2007, 1 (06) :583-592
[35]   Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists [J].
Davidson, Michael H. ;
Ballantyne, Christie M. ;
Jacobson, Terry A. ;
Bittner, Vera A. ;
Braun, Lynne T. ;
Brown, Alan S. ;
Brown, W. Virgil ;
Cromwell, William C. ;
Goldberg, Ronald B. ;
McKenney, James M. ;
Remaley, Alan T. ;
Sniderman, Allan D. ;
Toth, Peter P. ;
Tsimikas, Sotirios ;
Ziajka, Paul E. ;
Maki, Kevin C. ;
Dicklin, Mary R. .
JOURNAL OF CLINICAL LIPIDOLOGY, 2011, 5 (05) :338-367
[36]   Metabolic syndrome: A major risk factor for atherosclerosis in HIV-infected patients (SHIVA study) [J].
de Saint Martin, Luc ;
Pasquier, Elisabeth ;
Roudaut, Nathalie ;
Vandhuick, Olivier ;
Vallet, Sophie ;
Bellein, Veronique ;
Bressollette, Luc .
PRESSE MEDICALE, 2008, 37 (04) :579-584
[37]   Reduction in triglyceride level with N-3 polyunsaturated fatty acids in HIV-infected patients taking potent antiretroviral therapy - A randomized prospective study [J].
De Truchis, Pierre ;
Kirstetter, Myriam ;
Perier, Antoine ;
Meunier, Claire ;
Zucnian, David ;
Force, Gilles ;
Doll, Jacques ;
Katlama, Christine ;
Rozenbaum, Willy ;
Masson, Helene ;
Gardette, Jean ;
Melchior, Jean-Claude .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 44 (03) :278-285
[38]   Niacin in Cardiovascular Disease: Recent Preclinical and Clinical Developments [J].
Digby, Janet E. ;
Ruparelia, Neil ;
Choudhury, Robin P. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (03) :582-588
[39]  
Dube MP, 2006, ANTIVIR THER, V11, P1081
[40]   Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy:: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group [J].
Dubé, MP ;
Stein, JH ;
Aberg, JA ;
Fichtenbaum, CJ ;
Gerber, JG ;
Tashima, KT ;
Henry, WK ;
Currier, JS ;
Sprecher, D ;
Glesby, MJ .
CLINICAL INFECTIOUS DISEASES, 2003, 37 (05) :613-627